Neoadjuvant chemotherapy for resectable adenocarcinoma of the panctreatic head - a prospective phase II trial

被引：0
|
作者：
Pestalozzi, B. C. [1 ]
Heinrich, S. [1 ]
Schafer, M. [1 ]
Pierre-Alain, C. [1 ]
机构：
[1] Univ Hosp Zurich, Zurich, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4610
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The Fate of Resectable Pancreatic Adenocarcinoma After Neoadjuvant Chemotherapy
    Irfan, Ahmer
    Rose, J. Bart
    Wang, Thomas N.
    Vickers, Selwyn M.
    Dudeja, Vikas
    Gbolahan, Olumide
    Reddy, Sushanth
    PANCREAS, 2022, 51 (01) : 100 - 105
  • [22] A Single-Arm, Nonrandomized Phase II Trial of Neoadjuvant Gemcitabine and Oxaliplatin in Patients With Resectable Pancreas Adenocarcinoma
    O'Reilly, Eileen M.
    Perelshteyn, Anna
    Jarnagin, William R.
    Schattner, Mark
    Gerdes, Hans
    Capanu, Marinela
    Tang, Laura H.
    LaValle, Joseph
    Winston, Corinne
    DeMatteo, Ronald P.
    D'Angelica, Michael
    Kurtz, Robert C.
    Abou-Alfa, Ghassan K.
    Klimstra, David S.
    Lowery, Maeve A.
    Brennan, Murray F.
    Coit, Daniel G.
    Reidy, Diane L.
    Kingham, T. Peter
    Allen, Peter J.
    ANNALS OF SURGERY, 2014, 260 (01) : 142 - 148
  • [23] A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared with Chemoradiotherapy in Locally Advanced Gastric Adenocarcinoma
    Wang, X.
    Jin, J.
    Zhao, D. B.
    Chi, Y. H. B. L.
    Yang, L.
    Jiang, L.
    Dou, L. Z.
    Tang, Y.
    Li, N.
    Liu, W., Jr.
    Tian, Y. T.
    Zhao, H.
    Che, X.
    Bai, X. F.
    Lu, N.
    Hua, R.
    Fang, H.
    Wang, S. L.
    Song, Y. W.
    Liu, Y.
    Li, Y. X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S29 - S30
  • [24] Efficacy of Neoadjuvant Chemotherapy and Radiation in Resectable/Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Kelley, Jesse K.
    Kolbeinsson, Hordur
    Eastburg, Benjamin
    Frisch, Austin
    Khan, Mariam
    Wright, Gerald P.
    Assifi, Mura
    Chandra, Sreenivasa
    Chung, Mathew
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S176 - S177
  • [25] Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 Trial
    Fuyuhiko Motoi
    Kazuyuki Ishida
    Fumiyoshi Fujishima
    Shigeru Ottomo
    Masaya Oikawa
    Takaho Okada
    Hiromune Shimamura
    Shinichi Takemura
    Fuminori Ono
    Masanori Akada
    Kei Nakagawa
    Yu Katayose
    Shinichi Egawa
    Michiaki Unno
    Annals of Surgical Oncology, 2013, 20 : 3794 - 3801
  • [26] Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 Trial
    Motoi, Fuyuhiko
    Ishida, Kazuyuki
    Fujishima, Fumiyoshi
    Ottomo, Shigeru
    Oikawa, Masaya
    Okada, Takaho
    Shimamura, Hiromune
    Takemura, Shinichi
    Ono, Fuminori
    Akada, Masanori
    Nakagawa, Kei
    Katayose, Yu
    Egawa, Shinichi
    Unno, Michiaki
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (12) : 3794 - 3801
  • [27] INDUCTION CHEMOTHERAPY IN PRIMARY RESECTABLE HEAD AND NECK TUMORS - A PROSPECTIVE RANDOMIZED TRIAL
    VOLLING, P
    SCHRODER, M
    MULLER, RP
    EBELING, O
    QUIRIN, R
    STENNERT, E
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 4 (04) : 909 - 914
  • [28] Neoadjuvant phase II trial of chemo-radiotherapy (CRT) in patients with resectable (R) and borderline resectable (BR) pancreatic ductal adenocarcinoma (PDA)
    Damarla, V.
    Dobrosotskaya, D.
    Siddiqui, F.
    Wollner, I.
    Raoufi, M.
    Li, J.
    Kwon, D.
    Khan, G.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S8 - S9
  • [29] A phase II study of neoadjuvant chemotherapy with DCS for resectable advanced esophageal cancer
    Kitadani, Junya
    Nakamura, Masaki
    Ojima, Toshiyasu
    Katsuda, Masahiro
    Hayata, Keiji
    Yamaue, Hiroki
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [30] Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: Prospective phase II trial
    Velenik, Vaneja
    Anderluh, Franc
    Oblak, Irena
    Strojan, Primoz
    Zakotnik, Branko
    CROATIAN MEDICAL JOURNAL, 2006, 47 (05) : 693 - 700
12345